Results of our stem cell treatments
The results our patients have achieved by taking our stem cell treatment can be found below. When more results for differing diseases become available, they will be added to this page and to their specific pages.
Please keep in mind that almost all diseases we treat are degenerative. This means that when nothing is done, the health condition will almost certainly deteriorate. Achieving a stable situation -a "no change" result- can be a success in and of itself.
Cerebral Palsy
Follow up statistics from 100 cerebral palsy patients completed in March 2010 show that close to 70% experienced improvements after stem cell therapy.
The mean age of the patients was 10.8 years. The oldest treated patient was 61 years of age.
The type of improvements reported include: decreased spasticity; better coordination; improved motor function, improved posture stability; better cognition resulting in communication improvements; gaining the ability to sit, stand or even walk unassisted.
Improved speech articulation was observed in 56% of patients. 43% reported a significant decrease or even absence of epileptic seizures following treatment.
Click to go to detailed Cerebral Palsy treatment results, including graphs.
Spinal Cord Injury
Follow up statistics from 140 spinal cord injury patients completed in March 2010 show that nearly 60% experienced improvements after stem cell therapy.
These improvements were reported by patients with both incomplete and complete injuries in similar proportions.
Getting back sensation (feeling warm or cold sensations/ touch) was reported in 67% of improved patients. Less weakness and increased muscle duration was reported by about two-thirds. Better control of Bladder and Bowel and even getting back erections was also reported by 25% - 40% of the patients.
Click to go to detailed spinal cord treatment results, including more graphs.
Diabetes mellitus
Follow up statistics from 50 diabetes patients completed in July 2009 show that more than 50% experienced improvements after stem cell therapy.
40% of the patients were insulin dependent (type 1) and 60% were non-insulin dependent (type 2). About 4 of 5 patients were male and the average age was 51 years old.
Approximately 1/3 of insulin dependent patients improved following treatment while about 2/3 of non-insulin dependent patients improved.

Overall, improvements reported included more stable blood glucose levels, lower fasting blood glucose levels, decreased leg pain, lower blood pressure and the elimination of hypoglycemic episodes.
Nearly 1 in 4 male patients regained erectile function.
Please see Diabetes Treatment Results (PDF file) for the complete study.
Parkinson's disease
50 patients with Parkinson's disease were treated with Autologous stem cells by the XCell-Center. Nearly 60% of patients treated reported an improvement in their condition after treatment. 60% of the patients who reported improvements had them confirmed by their personal physician.

Approximately 60% of improved patients reported better speech, handwriting and ability to use utensils. About 1/3 experienced improved ability to swallow and control saliva (drooling).
3 out of 4 patients who improved experienced decreased rigidity and a little more than half reported decreased tremors. Over 85% reported improved walking ability. While greater than 80% experienced improved gait.

Click to go to detailed Parkinson's results including more graphs.
Stroke
Follow up statistics from 60 diabetes stroke patients completed in March 2010 show that more than 55% experienced improvements after stem cell therapy. Approximately 2/3 of the patients treated were male.
47 patients were treated via lumbar puncture and 13 by surgical implantation. The average patient age was 50 years-old and the average follow-up time after treatment was about 9 months. First positive effects from the treatment were experienced by patients after an average of about 2 months.
About 2/3 of patients who improved reported better arm use and coordination and improved motor skills in their hands and fingers. Roughly 3 out of 4 patients experienced improved leg use and coordination as well as an increased ability to stand and walk unassisted. Speech improved in more than 75% while vision improved in half.
Click to go to complete Stroke treatment results including graphs.
Multiple Sclerosis
In the bar chart below you can see the results of an evaluation
of 19 multiple sclerosis patients. The data was collected
one to six months after the treatment.
- Seven out of 19 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
- Eight out of 19 patients reported an improvement, with reduced spasticity and/or improved sensation and or/ improved mobility and/or a reduction in fatigue.
- Three out of 19 patients reported a strong improvement, with an absence of spasticity and/or a marked improvement of sensation and/or marked improvement in mobility. They also reported improved bladder control and/or better vision and/or a marked reduction of fatigue.
- One patient reported a perceived deterioration of the quality of his life. The treatment could neither stop nor reverse the advance of the MS symptoms.
ALS
In the bar chart below you can see the evaluation of 53
amyotrophic lateral sclerosis patients. The data was collected one
to six months after the treatment.
- 16 out of 53 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
- 19 out of 53 patients reported an improvement, with improved mobility (legs, arms) and/or improved breathing and or/ improved strength. Some patients reported a regain of muscles and/or an improvement of balance, sleeping or a reduction of spasms.
- One out of 53 patients reported a strong improvement, with a marked improvement of mobility, breathing, speech and swallowing.
- 17 out of 53 patients reported a perceived deterioration of the quality of their life. A majority of these patients saw a reduction of mobility, strength, speech/swallowing or balance. The treatment could neither stop nor reverse the advance of the ALS symptoms. It is believed that the treatment has not adversely affected the patients.



